Mehmet Dal to Adult
This is a "connection" page, showing publications Mehmet Dal has written about Adult.
Connection Strength
0.055
-
COVID-19 clinical course and blood groups: Turkish population-based study Turk J Med Sci. 2021 08 30; 51(4):1659-1664.
Score: 0.016
-
Assessment of the underlying causes of the immune thrombocytopenia: Ten years experience. J Pak Med Assoc. 2017 Jul; 67(7):1004-1008.
Score: 0.012
-
Convalescent plasma therapy in patients with COVID-19. Transfus Apher Sci. 2021 Feb; 60(1):102955.
Score: 0.004
-
The outcome of COVID-19 in patients with hematological malignancy. J Med Virol. 2021 02; 93(2):1099-1104.
Score: 0.004
-
Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study Turk J Haematol. 2020 05 06; 37(2):84-90.
Score: 0.004
-
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience Turk J Haematol. 2019 11 18; 36(4):230-237.
Score: 0.003
-
Impact of Guideline-Driven Approach in Follow-Up of Long-Term Complications After Allogeneic Hematopoietic Cell Transplant: Single Center Experience. Exp Clin Transplant. 2020 06; 18(3):359-367.
Score: 0.003
-
Efficacy of CLARA in recurrent/refractory acute myeloid leukaemia patients unresponsive to FLAG chemotherapy. J Chemother. 2018 Feb; 30(1):44-48.
Score: 0.003
-
Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience. Hematol Oncol. 2018 Feb; 36(1):116-120.
Score: 0.003
-
Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting. Balkan Med J. 2017 Apr 05; 34(2):132-139.
Score: 0.003